ClinicalTrials.gg
CompletedNCT04408612Updated Nov 24, 2023

Dyspnea in Stable Patients With Coronary Artery Disease.

An observational study in Dyspnea and Coronary Artery Disease, sponsored by National Research Center for Preventive Medicine. Completed at 1 site in Russian Federation. Per ClinicalTrials.gov, last updated 2023-11-24.

Sponsored by National Research Center for Preventive Medicine · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
200
Sex
All
01

Study summary

Single-centre prospective study to characterize causes of dyspnea in stable patients with coronary artery disease and evaluate the possibility to determine the cause of dyspnea before in-depth examination.

Read the detailed description

Stable patients with dyspnea and coronary artery disease will be included in this single-centre prospective study. In addition to routine clinical examination patients will be interviewed to determine the nature of shortness of breath, angina, presence of chronic heart failure or anxiety using the Medical Research Council Dyspnea scale, the visual analog scale of dyspnea, Borg scale, modified "dictionary" of dyspnea, G. Rose questionnaire, Seattle Angina Questionnaire, Framingham criteria for chronic heart failure and the SHOCK scale. During the subsequent in-depth examination including thyroid hormones, NT-proBNP, hsTroponin, ECG monitoring, six-minute walk test, stress-echo with a diastolic stress test, spirometry and coronary angiography (if necessary) main reason for dyspnea will be established. Possibilities of early (before in-depth examination) determination the reason for dyspnea in stable patients with coronary artery disease will be evaluated.

02

Conditions studied

  • Dyspnea
  • Coronary Artery Disease

Keywords

  • Dyspnea
  • Stable coronary artery disease
  • Heart failure
  • Diastolic stress test
03

In context

Dyspnea

895 studies on the registry are indexed under Dyspnea; 189 are open to participants now.

This study's enrollment of 200 is above the median of 103 across 272 observational studies indexed under Dyspnea.

Browse Dyspnea studies →

Lead sponsor

National Research Center for Preventive Medicine is the lead sponsor of 18 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Stable patients with dyspnea and established coronary artery disease.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Stable patients with shortness of breath and established diagnosis of coronary artery disease (at least 1 of the following signs):

    • history of myocardial infarction;
    • typical angina without suspected other cause of pain;
    • myocardial ischemia documented by changes during symptoms and/or by results of the stress test;
    • coronary artery stenosis >50% according to coronary angiography.
  2. Signed .

Exclusion criteria

Exclusion Criteria:

  1. Acute coronary syndrome (myocardial infarction, unstable angina) in the previous month.
  2. Hospitalization with decompensation of CHF in the previous 6 months (including CHF decompensation as the main reason for current hospitalization).
  3. Diseases with an unfavourable prognosis (terminal CKD, CHF IV, a lung disease with severe respiratory failure).
  4. to bicycle stress echocardiography.
  5. Atrial Fibrillation at the time of hospitalization, when the decision not to restore the sinus rhythm.
  6. Mental illnesses and disorders, dementia, drug or alcohol dependence.
  7. Known oncological diseases.
Terms in these criteria, in plain language(4)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ECG (electrocardiogram)

A recording of the heart’s electrical activity, taken with stickers on the chest, arms and legs. It takes a few minutes and does not hurt.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

NYHA class (heart failure)

The New York Heart Association’s four classes of how much heart failure limits physical activity.

I
No limits: ordinary activity causes no undue tiredness or breathlessness.
II
Slight limits: comfortable at rest, ordinary activity causes symptoms.
III
Marked limits: comfortable at rest, less than ordinary activity causes symptoms.
IV
Symptoms even at rest; any activity makes them worse.

Studies set their own limit — many outside heart failure leave out class III–IV, while heart failure studies may ask for a particular class. Check the class this study names.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
200 participants (actual)
Patient registry
No
Biospecimen retention
Samples without dna

Groups and cohorts

  • Dyspnea in stable coronary artery disease

    Stable patients with dyspnea and coronary artery disease

    Diagnostic Test: Scales for assessment of symptoms

Interventions

  • Diagnostic testScales for assessment of symptoms

    Medical Research Council Dyspnea scale, the visual analogue scale of dyspnea, Borg scale, modified "dictionary" of dyspnea, G. Rose questionnaire, Seattle Angina Questionnaire, Framingham criteria for chronic heart failure, the SHOCK scale.

06

What researchers measure

Primary outcomes

  1. Myocardial ischemia as a reason of dyspnea

    Number of patient with dyspnea related to myocardial ischemia

    Time frame: up to 1 month

Secondary outcomes

  1. Other causes of dyspnea

    Number of patient with non-ischemic reasons for dyspnea (heart failure, pulmonary disease, arrhythmias, psychogenic, mixed or undetermined cases).

    Time frame: up to 1 month

  2. Adverse events

    Composite of death, myocardial infarction, stroke and rehospitalization

    Time frame: 6 months

07

Study locations

1 site
  • National Research Centre for Therapy and Preventive Medicine
    Moscow, Russian Federation
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jul 2020 to primary completion in Nov 2023, 39 months.

Of 116 non-industry observational studies under Dyspnea, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 47. This study's 39 months is above that.

Counting every sponsor, half of 125 studies reached it within 24 months; a quarter within 11 and three quarters within 46.

How these figures are worked out, and which studies are left out of them.

Registered
May 10, 2020
First posted
May 29, 2020
StartActual
Jul 6, 2020
Primary completionActual
Nov 1, 2023
CompletionActual
Nov 1, 2023
Last update
Nov 24, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 24, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04408612
Lead sponsor
National Research Center for Preventive Medicine
Responsible party
Sponsor
First posted
May 29, 2020
Start date
Jul 6, 2020
Primary completion
Nov 1, 2023
Completion
Nov 1, 2023
Last update
Nov 24, 2023

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion